Literature DB >> 10080731

Thoracic CT findings in long-term hemodialysis patients.

M Coşkun1, F Boyvat, B Bozkurt, A M Agildere, E A Niron.   

Abstract

PURPOSE: To evaluate thoracic CT findings of long-term hemodialysis patients.
MATERIAL AND METHODS: Thoracic CT findings of 117 uremic patients (61 men, 56 women) with complaints of cough, dyspnea, low-grade pyrexia, malaise, weight loss, and profuse perspiration were retrospectively documented.
RESULTS: Atelectasis (60%), cardiomegaly (60%), pleural effusion (51%), vascular congestion (44%), parenchymal consolidation (38%), parenchymal scarring-fibrosis (31%), and lymphadenopathy (29%) were the most common CT findings in the thoraces of the long-term hemodialysis patients. Staphylococcus aureus was detected in 13 patients (11%) who had parenchymal infiltration. Thoracic tuberculosis was identified in 15 patients (13%), 11 of these cases being confined to the lung parenchyma, 3 to the pleura, and 1 involving the pleura and pericardium.
CONCLUSION: In patients under long-term hemodialysis treatment, parenchymal consolidation, secondary to infectious agents such as S. aureus and Mycobacterium tuberculosis, is the most important CT finding since these lesions can be detected and treated successfully if they are considered as etiologic factors early on.

Entities:  

Mesh:

Year:  1999        PMID: 10080731     DOI: 10.3109/02841859909177735

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  2 in total

1.  Video-assisted thoracoscopic surgery for thoracic empyema in patients on maintenance hemodialysis.

Authors:  Hsien-Chi Liao; Jen-Hao Chuang; Hsao-Hsun Hsu; Ke-Cheng Chen; Jin-Shing Chen
Journal:  Surg Endosc       Date:  2019-07-08       Impact factor: 4.584

2.  Uremic lung: The "calcified cauliflower" sign in the end stage renal disease.

Authors:  Giuseppe Dilorenzo; Michele Telegrafo; Giuseppe Marano; Michele De Ceglie; Amato Antonio Stabile Ianora; Giuseppe Angelelli; Marco Moschetta
Journal:  Respir Med Case Rep       Date:  2016-10-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.